These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 18829874

  • 1. The perplexities of conducting randomized, double-blind, placebo-controlled treatment trials in anorexia nervosa patients.
    Halmi KA.
    Am J Psychiatry; 2008 Oct; 165(10):1227-8. PubMed ID: 18829874
    [No Abstract] [Full Text] [Related]

  • 2. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
    Bissada H, Tasca GA, Barber AM, Bradwejn J.
    Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642
    [Abstract] [Full Text] [Related]

  • 3. Successful olanzapine treatment of anorexia nervosa in a girl with pervasive developmental disorder not otherwise specified.
    Tateno M, Teshirogi H, Kamasaki H, Saito T.
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):752. PubMed ID: 19068020
    [No Abstract] [Full Text] [Related]

  • 4. An open trial of olanzapine in anorexia nervosa.
    Barbarich NC, McConaha CW, Gaskill J, La Via M, Frank GK, Achenbach S, Plotnicov KH, Kaye WH.
    J Clin Psychiatry; 2004 Nov; 65(11):1480-2. PubMed ID: 15554759
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine therapy in anorexia nervosa: psychobiological effects.
    Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P, Ramaciotti C, Bondi E, Mellado C, Borriello R, Monteleone P.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):197-204. PubMed ID: 17519642
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.
    Ayyıldız H, Turan Ş, Gülcü D, Poyraz CA, Pehlivanoğlu E, Çullu F, Arıkan MK.
    Eat Weight Disord; 2016 Jun; 21(2):309-11. PubMed ID: 26607823
    [No Abstract] [Full Text] [Related]

  • 7. Use of olanzapine in anorexia nervosa.
    Menaster M.
    J Clin Psychiatry; 2005 May; 66(5):654-5; author reply 655-6. PubMed ID: 15889956
    [No Abstract] [Full Text] [Related]

  • 8. [Olanzapine in the treatment of adolescents with anorexia nervosa].
    Hein IM, Huyser C.
    Tijdschr Psychiatr; 2010 May; 52(6):417-21. PubMed ID: 20544600
    [Abstract] [Full Text] [Related]

  • 9. Predictors of premature termination of anorexia nervosa treatment.
    Godart NT, Rein Z, Perdereau F, Curt F, Jeammet P.
    Am J Psychiatry; 2005 Dec; 162(12):2398-9; author reply 2399. PubMed ID: 16330619
    [No Abstract] [Full Text] [Related]

  • 10. Drop outs from in-patient treatment of anorexia nervosa.
    Zeeck A, Hartmann A, Buchholz C, Herzog T.
    Acta Psychiatr Scand; 2005 Jan; 111(1):29-37. PubMed ID: 15636591
    [Abstract] [Full Text] [Related]

  • 11. Moderators of weight gain in the early stages of outpatient cognitive behavioral therapy for adults with anorexia nervosa.
    Lockwood R, Serpell L, Waller G.
    Int J Eat Disord; 2012 Jan; 45(1):51-6. PubMed ID: 22170020
    [Abstract] [Full Text] [Related]

  • 12. Psychopharmacology in the treatment of anorexia nervosa and bulimia nervosa.
    Hoffman L, Halmi K.
    Psychiatr Clin North Am; 1993 Dec; 16(4):767-78. PubMed ID: 7906029
    [Abstract] [Full Text] [Related]

  • 13. Emotional Expression Predicts Treatment Outcome in Focal Psychodynamic and Cognitive Behavioural Therapy for Anorexia Nervosa: Findings from the ANTOP Study.
    Friederich HC, Brockmeyer T, Wild B, Resmark G, de Zwaan M, Dinkel A, Herpertz S, Burgmer M, Löwe B, Tagay S, Rothermund E, Zeeck A, Zipfel S, Herzog W.
    Psychother Psychosom; 2017 Dec; 86(2):108-110. PubMed ID: 28183091
    [No Abstract] [Full Text] [Related]

  • 14. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.
    McClellan JM.
    Am J Psychiatry; 2007 Oct; 164(10):1462-4. PubMed ID: 17898331
    [No Abstract] [Full Text] [Related]

  • 15. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
    Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC.
    Am J Psychiatry; 2005 May; 162(5):954-62. PubMed ID: 15863798
    [Abstract] [Full Text] [Related]

  • 16. Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.
    Liu-Seifert H, Adams DH, Kinon BJ.
    BMC Med; 2005 Dec 23; 3():21. PubMed ID: 16375765
    [Abstract] [Full Text] [Related]

  • 17. Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis.
    Block JJ.
    Am J Psychiatry; 2006 Oct 23; 163(10):1838; author reply 1838. PubMed ID: 17012701
    [No Abstract] [Full Text] [Related]

  • 18. Olanzapine-induced hyperglycemia in anorexia nervosa.
    Yasuhara D, Nakahara T, Harada T, Inui A.
    Am J Psychiatry; 2007 Mar 23; 164(3):528-9. PubMed ID: 17329484
    [No Abstract] [Full Text] [Related]

  • 19. Orthorexia nervosa in dieticians.
    Kinzl JF, Hauer K, Traweger C, Kiefer I.
    Psychother Psychosom; 2006 Mar 23; 75(6):395-6. PubMed ID: 17053342
    [No Abstract] [Full Text] [Related]

  • 20. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH.
    J Clin Psychiatry; 2004 Mar 23; 65 Suppl 18():47-56. PubMed ID: 15600384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.